• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种MK2抑制剂复合物的结构分析:TEI-I01800对富含甘氨酸环二级结构调控的见解。

Structural analysis of an MK2-inhibitor complex: insight into the regulation of the secondary structure of the Gly-rich loop by TEI-I01800.

作者信息

Fujino Aiko, Fukushima Kei, Namiki Naoko, Kosugi Tomomi, Takimoto-Kamimura Midori

机构信息

Teijin Institute for Biomedical Research, Japan.

出版信息

Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):80-7. doi: 10.1107/S0907444909046411. Epub 2009 Dec 21.

DOI:10.1107/S0907444909046411
PMID:20057052
Abstract

Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2 or MK2) is a Ser/Thr kinase from the p38 mitogen-activated protein kinase signalling pathway and plays an important role in inflammatory diseases. The crystal structure of the complex of human MK2 (residues 41-364) with the potent MK2 inhibitor TEI-I01800 (pK(i) = 6.9) was determined at 2.9 A resolution. The MK2 structure in the MK2-TEI-I01800 complex is composed of two domains, as observed for other Ser/Thr kinases; however, the Gly-rich loop in the N-terminal domain forms an alpha-helix structure and not a beta-sheet. TEI-I01800 binds to the ATP-binding site as well as near the substrate-binding site of MK2. Both TEI-I01800 molecules have a nonplanar conformation that differs from those of other MK2 inhibitors deposited in the Protein Data Bank. The MK2-TEI-I01800 complex structure is the first active MK2 with an alpha-helical Gly-rich loop and TEI-I01800 regulates the secondary structure of the Gly-rich loop.

摘要

丝裂原活化蛋白激酶激活的蛋白激酶2(MAPKAP-K2或MK2)是p38丝裂原活化蛋白激酶信号通路中的一种丝氨酸/苏氨酸激酶,在炎症性疾病中起重要作用。已在2.9埃分辨率下确定了人MK2(第41-364位残基)与强效MK2抑制剂TEI-I01800(pK(i)=6.9)复合物的晶体结构。与其他丝氨酸/苏氨酸激酶一样,MK2-TEI-I01800复合物中的MK2结构由两个结构域组成;然而,N端结构域中富含甘氨酸的环形成的是α螺旋结构而非β折叠。TEI-I01800与MK2的ATP结合位点以及底物结合位点附近结合。两个TEI-I01800分子均具有非平面构象,这与蛋白质数据库中存放的其他MK2抑制剂不同。MK2-TEI-I01800复合物结构是首个具有α螺旋富含甘氨酸环的活性MK2,且TEI-I01800可调节富含甘氨酸环的二级结构。

相似文献

1
Structural analysis of an MK2-inhibitor complex: insight into the regulation of the secondary structure of the Gly-rich loop by TEI-I01800.一种MK2抑制剂复合物的结构分析:TEI-I01800对富含甘氨酸环二级结构调控的见解。
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):80-7. doi: 10.1107/S0907444909046411. Epub 2009 Dec 21.
2
Structure of the β-form of human MK2 in complex with the non-selective kinase inhibitor TEI-L03090.与非选择性激酶抑制剂TEI-L03090结合的人MK2β形式的结构。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Dec;69(Pt 12):1344-8. doi: 10.1107/S1744309113030534. Epub 2013 Nov 28.
3
Assessment of the putative binding conformation of a pyrazolopyridine class of inhibitors of MAPKAPK2 using computational studies.使用计算研究评估 MAPKAPK2 抑制剂的吡唑并吡啶类化合物的假定结合构象。
Eur J Med Chem. 2010 Jan;45(1):98-105. doi: 10.1016/j.ejmech.2009.09.030. Epub 2009 Sep 30.
4
Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity.人细胞周期蛋白依赖性激酶-2 复合物与 MK2 抑制剂 TEI-I01800 的晶体结构:选择性的深入了解。
J Synchrotron Radiat. 2013 Nov;20(Pt 6):905-9. doi: 10.1107/S0909049513020736. Epub 2013 Sep 26.
5
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode.2,4-二氨基嘧啶 MK2 抑制剂。第一部分:观察到一种意想不到的抑制剂结合模式。
Bioorg Med Chem Lett. 2010 Jan 1;20(1):330-3. doi: 10.1016/j.bmcl.2009.10.102. Epub 2009 Oct 29.
6
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization.2,4-二氨基嘧啶 MK2 抑制剂。第二部分:基于结构的抑制剂优化。
Bioorg Med Chem Lett. 2010 Jan 1;20(1):334-7. doi: 10.1016/j.bmcl.2009.10.103. Epub 2009 Oct 29.
7
Structural basis for a high affinity inhibitor bound to protein kinase MK2.与蛋白激酶MK2结合的高亲和力抑制剂的结构基础
J Mol Biol. 2007 Jun 8;369(3):735-45. doi: 10.1016/j.jmb.2007.03.004. Epub 2007 Mar 12.
8
Catalysis and function of the p38 alpha.MK2a signaling complex.p38α.MK2a信号复合体的催化作用与功能
Biochemistry. 2004 Aug 10;43(31):9950-60. doi: 10.1021/bi049508v.
9
Multiple and single binding modes of fragment-like kinase inhibitors revealed by molecular modeling, residue type-selective protonation, and nuclear overhauser effects.通过分子建模、残基类型选择性质子化和核Overhauser效应揭示的类片段激酶抑制剂的多种和单一结合模式
J Med Chem. 2008 Oct 9;51(19):6225-9. doi: 10.1021/jm800747w. Epub 2008 Sep 5.
10
Structure-based lead identification of ATP-competitive MK2 inhibitors.基于结构的 ATP 竞争型 MK2 抑制剂的先导化合物鉴定。
Bioorg Med Chem Lett. 2011 Jun 15;21(12):3818-22. doi: 10.1016/j.bmcl.2011.04.018. Epub 2011 Apr 16.

引用本文的文献

1
Genome-Wide Identification and Analysis of Transcription Factors in .……中转录因子的全基因组鉴定与分析
Plants (Basel). 2023 Oct 19;12(20):3613. doi: 10.3390/plants12203613.
2
Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials.靶向丝裂原活化蛋白激酶激活的蛋白激酶2(MAPKAPK2,MK2):推动小分子抑制剂进入临床试验的药物化学研究工作
J Med Chem. 2016 Apr 28;59(8):3609-34. doi: 10.1021/acs.jmedchem.5b01457. Epub 2015 Nov 9.
3
Structure of the β-form of human MK2 in complex with the non-selective kinase inhibitor TEI-L03090.
与非选择性激酶抑制剂TEI-L03090结合的人MK2β形式的结构。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Dec;69(Pt 12):1344-8. doi: 10.1107/S1744309113030534. Epub 2013 Nov 28.
4
Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity.人细胞周期蛋白依赖性激酶-2 复合物与 MK2 抑制剂 TEI-I01800 的晶体结构:选择性的深入了解。
J Synchrotron Radiat. 2013 Nov;20(Pt 6):905-9. doi: 10.1107/S0909049513020736. Epub 2013 Sep 26.